BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khasag O, Boldbaatar G, Tegshee T, Duger D, Dashdorj A, Uchida T, Matsuhisa T, Yamaoka Y. The prevalence of Helicobacter pylori infection and other risk factors among Mongolian dyspeptic patients who have a high incidence and mortality rate of gastric cancer. Gut Pathog 2018;10:14. [PMID: 29636824 DOI: 10.1186/s13099-018-0240-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Byambajav TO, Bira N, Choijamts G, Davaadorj D, Gantuya B, Sarantuya T, Sarantuya G, Enkhtsetseg A, Erdenetsogt D, Battulga A, Tserentogtokh T, Matsuhisa T, Yamaoka Y, Oyuntsetseg K. Initial Trials With Susceptibility-Based and Empiric Anti-H. pylori Therapies in Mongolia. Front Pharmacol 2019;10:394. [PMID: 31040783 DOI: 10.3389/fphar.2019.00394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Polivanova TV, Malaty H, Vshivkov VA. Epidemiology Helicobacter pylori infection in children in the Tyva Republic (Russia). Helicobacter. [DOI: 10.1111/hel.12882] [Reference Citation Analysis]
3 Azzaya D, Gantuya B, Oyuntsetseg K, Davaadorj D, Matsumoto T, Akada J, Yamaoka Y. High Antibiotic Resistance of Helicobacter pylori and Its Associated Novel Gene Mutations among the Mongolian Population. Microorganisms 2020;8:E1062. [PMID: 32708761 DOI: 10.3390/microorganisms8071062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Imai Y, Chiba T, Kondo T, Kanzaki H, Kanayama K, Ao J, Kojima R, Kusakabe Y, Nakamura M, Saito T, Nakagawa R, Suzuki E, Nakamoto S, Muroyama R, Tawada A, Matsumura T, Nakagawa T, Kato J, Kotani A, Matsubara H, Kato N. Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer. Oncol Lett 2020;20:2161-8. [PMID: 32782533 DOI: 10.3892/ol.2020.11757] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
5 Altanbayar O, Amgalanbaatar A, Battogtokh C, Bayarjargal N, Belick D, Kohns Vasconcelos M, Mackenzie CR, Pfeffer K, Henrich B. Characterization of the cagA-gene in Helicobacter pylori in Mongolia and detection of two EPIYA-A enriched CagA types. International Journal of Medical Microbiology 2022;312:151552. [DOI: 10.1016/j.ijmm.2022.151552] [Reference Citation Analysis]
6 Amgalanbaatar A, Shimomura H, Sugano K, Bira T, Okamoto H, Hirai Y. Correlation between Helicobacter pylori Infection and Gastric Atrophy Examined in the Sera of Mongolian People. GastrointestDisord 2019;1:241-52. [DOI: 10.3390/gidisord1020019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zheng J, Zhang G, Gao C, Xu G, Lin W, Jiang C, Li D, Wang W. Linked color imaging-based endoscopic grading of gastric intestinal metaplasia and histological gastritis staging in the assessment of gastric cancer risk. Scand J Gastroenterol 2022;:1-7. [PMID: 35701150 DOI: 10.1080/00365521.2022.2085061] [Reference Citation Analysis]
8 Gantuya B, El Serag HB, Saruuljavkhlan B, Azzaya D, Matsumoto T, Uchida T, Oyuntsetseg K, Oyunbileg N, Davaadorj D, Yamaoka Y. Advantage of 16S rRNA amplicon sequencing in Helicobacter pylori diagnosis. Helicobacter 2021;26:e12790. [PMID: 33596345 DOI: 10.1111/hel.12790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Sjomina O, Pavlova J, Niv Y, Leja M. Epidemiology of Helicobacter pylori infection. Helicobacter. 2018;23 Suppl 1:e12514. [PMID: 30203587 DOI: 10.1111/hel.12514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 15.7] [Reference Citation Analysis]
10 Eslami M, Yousefi B, Kokhaei P, Jazayeri Moghadas A, Sadighi Moghadam B, Arabkari V, Niazi Z. Are probiotics useful for therapy of Helicobacter pylori diseases? Comparative Immunology, Microbiology and Infectious Diseases 2019;64:99-108. [DOI: 10.1016/j.cimid.2019.02.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
11 Yu H, Mao Y, Cong L, Wang Z, Zhang H, Wang L. Prevalence and genotyping of Helicobacter pylori in endoscopic biopsy samples from a Chinese population. LaboratoriumsMedizin 2018;0:20180022. [DOI: 10.1515/labmed-2018-0022] [Reference Citation Analysis]
12 Tserentogtokh T, Gantuya B, Subsomwong P, Oyuntsetseg K, Bolor D, Erdene-Ochir Y, Azzaya D, Davaadorj D, Uchida T, Matsuhisa T, Yamaoka Y. Western-Type Helicobacter pylori CagA are the Most Frequent Type in Mongolian Patients. Cancers (Basel) 2019;11:E725. [PMID: 31137742 DOI: 10.3390/cancers11050725] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
13 Esmaeilzadeh A, Goshayeshi L, Bergquist R, Jarahi L, Khooei A, Fazeli A, Mosannen Mozaffari H, Bahari A, Oghazian MB, Hoseini B. Characteristics of gastric precancerous conditions and Helicobacter pylori infection among dyspeptic patients in north-eastern Iran: is endoscopic biopsy and histopathological assessment necessary? BMC Cancer 2021;21:1143. [PMID: 34702194 DOI: 10.1186/s12885-021-08626-6] [Reference Citation Analysis]
14 Jonaitis L, Pellicano R, Kupcinskas L. Helicobacter pylori and nonmalignant upper gastrointestinal diseases. Helicobacter. 2018;23 Suppl 1:e12522. [PMID: 30203583 DOI: 10.1111/hel.12522] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]